Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Non-canonical functions of claudin proteins: Beyond the regulation of cell-cell adhesions.

Hagen SJ.

Tissue Barriers. 2017 Apr 3;5(2):e1327839. doi: 10.1080/21688370.2017.1327839. Epub 2017 May 19.

PMID:
28548895
2.

Overexpressed Claudin-1 Can Be Visualized Endoscopically in Colonic Adenomas In Vivo.

Rabinsky EF, Joshi BP, Pant A, Zhou J, Duan X, Smith A, Kuick R, Fan S, Nusrat A, Owens SR, Appelman HD, Wang TD.

Cell Mol Gastroenterol Hepatol. 2015 Dec 13;2(2):222-237. eCollection 2016 Mar.

3.

Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis.

Chen X, Zhao J, Li A, Gao P, Sun J, Song Y, Liu J, Chen P, Wang Z.

Onco Targets Ther. 2016 May 27;9:3205-12. doi: 10.2147/OTT.S99461. eCollection 2016.

4.

Prognostic significance of claudin-1 and cyclin B1 protein expression in patients with hypopharyngeal squamous cell carcinoma.

Li W, Dong Q, Li L, Zhang Z, Cai X, Pan X.

Oncol Lett. 2016 May;11(5):2995-3002. Epub 2016 Mar 16.

5.

Gene Expression Profiling of Gastric Cancer.

Marimuthu A, Jacob HK, Jakharia A, Subbannayya Y, Keerthikumar S, Kashyap MK, Goel R, Balakrishnan L, Dwivedi S, Pathare S, Dikshit JB, Maharudraiah J, Singh S, Sameer Kumar GS, Vijayakumar M, Veerendra Kumar KV, Premalatha CS, Tata P, Hariharan R, Roa JC, Prasad TS, Chaerkady R, Kumar RV, Pandey A.

J Proteomics Bioinform. 2011 Apr;4(4):74-82. Epub 2011 Apr 16.

6.

Upregulated long intergenic noncoding RNA KRT18P55 acts as a novel biomarker for the progression of intestinal-type gastric cancer.

Ma B, Wang J, Song Y, Gao P, Sun J, Chen X, Yang Y, Wang Z.

Onco Targets Ther. 2016 Jan 21;9:445-53. doi: 10.2147/OTT.S98613. eCollection 2016.

7.

Tight junction disruption: Helicobacter pylori and dysregulation of the gastric mucosal barrier.

Caron TJ, Scott KE, Fox JG, Hagen SJ.

World J Gastroenterol. 2015 Oct 28;21(40):11411-27. doi: 10.3748/wjg.v21.i40.11411. Review.

8.

Claudin-1, but not claudin-4, exhibits differential expression patterns between well- to moderately-differentiated and poorly-differentiated gastric adenocarcinoma.

Tokuhara Y, Morinishi T, Matsunaga T, Ohsaki H, Kushida Y, Haba R, Hirakawa E.

Oncol Lett. 2015 Jul;10(1):93-98. Epub 2015 May 14.

9.

Prognostic and clinical significance of claudin-4 in gastric cancer: a meta-analysis.

Liu JX, Wei ZY, Chen JS, Lu HC, Hao L, Li WJ.

World J Surg Oncol. 2015 Jun 25;13:207. doi: 10.1186/s12957-015-0626-2.

10.

Claudin 1 mediates tumor necrosis factor alpha-induced cell migration in human gastric cancer cells.

Shiozaki A, Shimizu H, Ichikawa D, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Iitaka D, Nakashima S, Nako Y, Liu M, Otsuji E.

World J Gastroenterol. 2014 Dec 21;20(47):17863-76. doi: 10.3748/wjg.v20.i47.17863.

11.

Claudin-1 enhances tumor proliferation and metastasis by regulating cell anoikis in gastric cancer.

Huang J, Zhang L, He C, Qu Y, Li J, Zhang J, Du T, Chen X, Yu Y, Liu B, Zhu Z.

Oncotarget. 2015 Jan 30;6(3):1652-65.

12.
13.

Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGFβ in claudin-low breast tumor cells.

Patsialou A, Wang Y, Pignatelli J, Chen X, Entenberg D, Oktay M, Condeelis JS.

Oncogene. 2015 May 21;34(21):2721-31. doi: 10.1038/onc.2014.226. Epub 2014 Aug 4.

14.

Overexpression of Claudin-1 is Associated with Advanced Clinical Stage and Invasive Pathologic Characteristics of Oral Squamous Cell Carcinoma.

Sappayatosok K, Phattarataratip E.

Head Neck Pathol. 2015 Jun;9(2):173-80. doi: 10.1007/s12105-014-0559-z. Epub 2014 Jul 31.

15.

Malignant transformation of hyperplastic gastric polyps: An immunohistochemical and pathological study of the changes of neoplastic phenotype.

Imura J, Hayashi S, Ichikawa K, Miwa S, Nakajima T, Nomoto K, Tsuneyama K, Nogami T, Saitoh H, Fujimori T.

Oncol Lett. 2014 May;7(5):1459-1463. Epub 2014 Mar 4.

16.

Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival.

Eftang LL, Esbensen Y, Tannæs TM, Blom GP, Bukholm IR, Bukholm G.

BMC Cancer. 2013 Dec 10;13:586. doi: 10.1186/1471-2407-13-586.

17.

Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases -2 expression in ovarian carcinoma.

Wang L, Jin X, Lin D, Liu Z, Zhang X, Lu Y, Liu Y, Wang M, Yang M, Li J, Quan C.

Diagn Pathol. 2013 Nov 19;8:190. doi: 10.1186/1746-1596-8-190.

18.

The claudin family of proteins in human malignancy: a clinical perspective.

Ding L, Lu Z, Lu Q, Chen YH.

Cancer Manag Res. 2013 Nov 8;5:367-75. doi: 10.2147/CMAR.S38294. Review.

19.

RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.

Cross-Knorr S, Lu S, Perez K, Guevara S, Brilliant K, Pisano C, Quesenberry PJ, Resnick MB, Chatterjee D.

BMC Cancer. 2013 Oct 8;13:463. doi: 10.1186/1471-2407-13-463.

20.

Emerging roles of claudins in human cancer.

Kwon MJ.

Int J Mol Sci. 2013 Sep 4;14(9):18148-80. doi: 10.3390/ijms140918148. Review.

Supplemental Content

Support Center